The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure reagents from 10X Genomics, Inc. for the Critical Care Medicine Department (CCMD). This procurement aims to acquire in-vitro diagnostic substances, which are crucial for various medical testing and research applications within the department. The reagents will play a significant role in enhancing diagnostic capabilities and supporting critical care initiatives. Interested vendors can reach out to Tasha Lowe at lowet2@mail.nih.gov or call 301-402-6147 for further information regarding this presolicitation opportunity, which is set to take place in Bethesda, Maryland.